DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

DIGITAL CONTENT

4 NEWS #PharmaBuzz

media
4 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 872365-14-5, Nvp-qaw039, Qaw039, Fevipiprant [inn], 2pex5n7dq4, Fevipiprant(nvp-qaw039)

Molecular Formula

C₁₉H₁₇F₃N₂O₄S

Molecular Weight

426.4 g/mol

InChI Key

GFPPXZDRVCSVNR-UHFFFAOYSA-N

FDA UNII

2PEX5N7DQ4

Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.

1 2D Structure

Fevipiprant

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid

2.1.2 InChI

InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)

2.1.3 InChI Key

GFPPXZDRVCSVNR-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O

2.2 Other Identifiers

2.2.1 UNII

2PEX5N7DQ4

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

2. Nvp-qaw039

2.3.2 Depositor-Supplied Synonyms

1. 872365-14-5

2. Nvp-qaw039

3. Qaw039

4. Fevipiprant [inn]

5. 2pex5n7dq4

6. Fevipiprant(nvp-qaw039)

7. Qaw-039

8. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic Acid

9. (1-(4-((methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

10. 2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

11. 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

12. 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1h-pyrrolo[2,3-b]pyridine-3-acetic Acid

13. Fevipiprant [usan:inn]

14. Unii-2pex5n7dq4

15. Qaw 039

16. Fevipiprant [jan]

17. Fevipiprant [usan]

18. Fevipiprant [who-dd]

19. Fevipiprant (jan/usan/inn)

20. Gtpl8995

21. Schembl1940595

22. Chembl3137332

23. Dtxsid501336031

24. Hms3743e19

25. Bcp25015

26. Ex-a2495

27. Bdbm50233520

28. Mfcd22548206

29. Zinc43101772

30. Ab85348

31. Cs-5956

32. Db12011

33. Fevipiprant; Nvp-qaw039; Qaw039

34. Sb16897

35. Ac-31956

36. As-74870

37. Hy-16768

38. Ds-022511

39. Ft-0774596

40. D10631

41. Q27077292

42. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

43. (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

44. [1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-acetic Acid

45. [2-methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]acetic Acid

46. 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

47. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic Acid

48. Fsy

2.4 Create Date

2007-12-10

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₇F₃N₂O₄S
Molecular Weight	426.4 g/mol
XLogP3	2.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	5
Exact Mass	426.08611269 g/mol
Monoisotopic Mass	426.08611269 g/mol
Topological Polar Surface Area	97.6 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	709
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1